
|Articles|September 1, 2002
Women First HealthCare acquires Vaniqa, plans relaunch
San Diego - With its acquisition from Bristol-Myers Squibb of worldwide rights and title to Vaniqa (eflornithine hydrochloride) Cream, Women First HealthCare plans to take another pass at providing women with hirsutism a pharmaceutical alternative.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
KT-621 Produces 98% STAT6 Degradation in AD Patients
3
DeepSeek-R1 Outperforms ChatGPT-4o in Urticaria Clinical Queries
4
Abeona Initiates First Commercial Treatment of Zevaskyn for RDEB
5



















